Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Global Industry Analysis Report on Companion Diagnostics Market

New Market Research Report Added in MarketResearchReports.Biz Reports Database Companion Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

12 Sep 2013

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.

12 Sep 2013

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

They say a phone call can change your life and for colorectal or bowel cancer survivors this is true, a new study by a QUT researcher has found.

12 Sep 2013

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on Epigenomics AG.

7 Sep 2013

Trovagene, University of Southern California enter into clinical collaboration agreement

Trovagene, Inc., a developer of molecular diagnostics for cancer monitoring, today announced that the Company has entered into a clinical collaboration agreement with the University of Southern California to study genomic characterizations of metastatic colorectal cancers using Trovagene's proprietary cell-free DNA assays.

6 Sep 2013

Mount Sinai researchers to study why African Americans less likely to receive CRC screenings

Researchers at the Icahn School of Medicine at Mount Sinai have received a multi-year National Institutes of Health grant to determine factors which may influence why African Americans are less likely than others to receive colorectal cancer screenings, despite having the highest CRC incidence and mortality of any ethnic/racial group in America.

5 Sep 2013

New method to detect genetic variations that initiate colon cancer

A new, highly sensitive method to detect genetic variations that initiate colon cancer could be readily used for noninvasive colon cancer screening, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.

4 Sep 2013

European Commission approves Stivarga tablets for treatment of patients with mCRC

Bayer HealthCare and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) announced today that the European Commission has approved Stivarga® (regorafenib) tablets for the treatment of adult patients with metastatic colorectal cancer (mCRC).

30 Aug 2013

LLS survey uncovers alarming lack of knowledge among U.S. adults about blood cancers

Less than one half (46%) of adults polled in a new survey believe that blood cancers are one of three leading causes of cancer death in the U.S. In fact, blood cancers are the third leading cause of cancer death, behind cancers of the respiratory system, including lung cancer, and cancers of the digestive system, including colorectal cancer.

30 Aug 2013

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

Combining fecal immunological test and colonoscopy may improve detection of colorectal cancer

A strategy that combines two effective colorectal cancer screening methods, fecal immunological test and colonoscopy, may improve prevention and detection of colorectal cancer and reduce costs, according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

28 Aug 2013

Wait times for colorectal cancer procedures at VA hospitals increase to 32 days

A study published in the August print issue of the Journal of Oncology Practice shows that from 1998-2008, wait times for colorectal cancer operations at Veterans Administration hospitals increased from 19 to 32 days. But researchers think longer waits may be a reflection of several unmeasured variables including more careful care, staffing, and patient conditions or preferences.

27 Aug 2013

Genenews Axes 60% Of Staff To Boost New JV

...

22 Aug 2013

NIH Grants $5.2M To Vanderbilt Colon Cancer Investigator

...

22 Aug 2013

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Moffitt Cancer Center researchers suggest secondary cancers seen in melanoma patients who are being treated for a BRAF gene mutation may require new strategies, such as enhanced surveillance and combining BRAF-inhibitor therapy with other inhibitors, especially as they become more widely used.

17 Aug 2013

Researchers discover how common oral bacterium can contribute to colorectal cancer

Researchers from Case Western Reserve University School of Dental Medicine have discovered how a common oral bacterium can contribute to colorectal cancer, a finding that opens promising new research avenues for the development of approaches to prevent and treat the disease.

16 Aug 2013

Scientist develop mathematical model that predicts how individuals respond to cancer treatment

Vittorio Cristini, PhD, uses the example of an airplane to explain what he does in cancer research. "Before calculus," he says, "people couldn't really design a plane that would fly. You can do it by trial and error, but it would probably take centuries." Dr. Cristini has a faster way to try to understand cancer treatment. Like airplane designers today, he uses a mathematical model.

13 Aug 2013

Cancer-linked mitosis: an interview with Professor Scott Kern, Johns Hopkins University School of Medicine

Mitosis is the process by which a cell gives rise to two daughter cells. It’s the basis behind the growth of the human body, the renewal of the human body as it ages, and unfortunately, the growth of cancers.

7 Aug 2013

Study could boost development of personalised medicine in cancer care and therapy

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs. Having the means to identify patients who are most likely to benefit from currently available cancer drugs not only reduces substantially the healthcare cost for the patient, it could mean saving precious lives by getting the right drugs to the right patient at the onset of the treatment.

7 Aug 2013

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

A team of scientists led by Associate Professor Zeng Qi from A*STAR's Institute of Molecular and Cell Biology (IMCB) have discovered a new biomarker which will help physicians predict how well cancer patients respond to cancer drugs.

7 Aug 2013

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Global Industry Analysis Report on Companion Diagnostics Market

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Telephone delivered program improves health outcomes for people diagnosed with bowel cancer

S&P Capital IQ commences Standard & Poor's Factual Stock Report coverage on Epigenomics AG

Trovagene, University of Southern California enter into clinical collaboration agreement

Mount Sinai researchers to study why African Americans less likely to receive CRC screenings

New method to detect genetic variations that initiate colon cancer

European Commission approves Stivarga tablets for treatment of patients with mCRC

LLS survey uncovers alarming lack of knowledge among U.S. adults about blood cancers

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Combining fecal immunological test and colonoscopy may improve detection of colorectal cancer

Wait times for colorectal cancer procedures at VA hospitals increase to 32 days

Genenews Axes 60% Of Staff To Boost New JV

NIH Grants $5.2M To Vanderbilt Colon Cancer Investigator

Secondary cancers in melanoma patients treated for BRAF gene mutation require new strategies

Researchers discover how common oral bacterium can contribute to colorectal cancer

Scientist develop mathematical model that predicts how individuals respond to cancer treatment

Cancer-linked mitosis: an interview with Professor Scott Kern, Johns Hopkins University School of Medicine

Study could boost development of personalised medicine in cancer care and therapy

Scientists discover biomarker that helps physicians predict how well cancer patients respond to drugs

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in